Evaluation of Respiratory Function and Functional Capacity in Pediatric Patients With Chronic Kidney Disease (CKD)

Acibadem University

Status: Completed

Conditions: Chronic Kidney Diseases; Chronic Renal Disease; Chronic Renal Failure

Treatments: Other: 6 minute walk test,

Study type: Observational

Funder types: Other

Identifiers

NCT05339997

ırmak çavuşoğlu

Details and patient eligibility

About

Chronic kidney disease (CKD) is defined as a permanent abnormality in kidney structure or function that persists for more than 3 months (for example, glomerular filtration rate [GFR] <60 mL/min/1.73 m2 or albuminuria ≥30 mg/24 hours) and, it effects the 8% to 16% of the population worldwide.In pediatric patients with CKD, exercise capacity begins to decline in stage 3 of the disease and progressively decreases in stage 5, in dialysis and transplant patients (4, 5). Reduction in respiratory muscle strength and six minute walk test (6MWT) is observed in patients with CKD treated with hemodialysis (HD).The aim in present study is to evaluate the relationship between functional capacity and respiratory functions in stage 1-5 pediatric chronic kidney disease patients.

Full description

The aim of this study is to evaluate functional capacity with six minutes walk test (6MWT), respiratory functions with spirometer and the correlation between functional capacity and respiratory functions in pediatric CKD patients.

Enrollment: 30 patients

Sex: All

Ages: 5 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being between the ages of 5-18, having stage I-V chronic kidney disease,
• Having chronic kidney disease for at least 6 months,
• Not having visual and hearing impairment

Exclusion criteria

Presence of mental retardation,

• Insufficient Turkish communication, Inability to communicate,
• Having metabolic-neurological problems,
• Presence of cardiomyopathy, angina pectoris,
• Presence of orthopedic problem that will prevent standing and walking
• Cerebrovascular disease
• Patients will not be included in the study in the presence of metastatic carcinoma.